Within3 works for some organisations. But for pharma, biotech and medcomms teams who need a genuine partner, Adelo is the alternative.
From £20,000 with no annual contract, Adelo delivers live, hybrid and async HCP engagement in one place, backed by proprietary intelligence built on 8.5 billion real-world data points. We configure compliance, branding and delivery around your programme.
When a pharmaceutical client needed HCP insights across Europe for a rare disease programme, we delivered a 92% engagement rate across 40 specialists — and finished ahead of schedule.
A 6-week programme. Completed in 5.
| Feature | • Adelo | • Within3 |
|---|---|---|
| Async engagement | Dynamic discussion boards, polls, surveys and resource libraries — all on one branded hub | Discussion boards and polling — async-first model |
| Live webinars | Studio-quality, fully interactive live sessions with real-time polling and Q&A | Limited live capability — platform built around async |
| Studio broadcast | High-production live and hybrid events | Not available |
| Advisory boards & KOL programmes | Full end-to-end delivery — we design, manage and report on your programme alongside you | Platform access only — programme design and delivery sits with your team |
| Compliance | Custom-built to your therapeutic area, jurisdiction and internal governance | Standard HIPAA, SOC 2, CFR Part 11 — no bespoke configuration |
| Launch intelligence | SDOH analysis, geomapping and publications tracking — has supported launches for top-20 pharma companies | Engagement reporting and aggregated data |
| Branding & design | Fully bespoke — branded to your programme | Standardised SaaS interface |
| Platform flexibility | Live, hybrid, async — configure the format that fits your programme, not ours | Async-first — limited format flexibility |
| Client support | Dedicated hands-on delivery team with you throughout — not a ticket system | Primarily self-serve |
| Contract | Flexible pay-per-use. No lock-in. | Enterprise annual contracts — typically 12 months minimum |
| Pricing | From £20,000 | Typically £100,000+ |
Map the social and environmental context shaping patient outcomes and HCP behaviour.
Map hyperlocal HCP and patient data to pinpoint unmet needs and drive your engagement strategy.
Monitor real-time publications and evidence to lead the scientific conversation in your market.
A proven methodology refined by top-20 pharma companies, now accessible to teams of every size.
Every advisory board and KOL programme has its own compliance requirements. Rather than offering a fixed framework and leaving you to adapt, Adelo works with you to configure the right guardrails — your therapeutic area, your markets, your governance.
Clear documentation and structured processes for advisory boards, steering committees and KOL engagements — built into every programme from the start.
Proactive off-label protections designed into the programme architecture, keeping your team protected without compromising the quality of engagement.
Structured AE capture workflows embedded directly into your programme — every event flagged, logged and escalated in line with your pharmacovigilance obligations.
No two programmes are the same. We configure compliance around your requirements — not a standardised template.
4 reasons pharma teams choose adelo over Within3
From programme design to final reporting, our hands-on delivery team works alongside you throughout.
Adelo is the only engagement platform that pairs live and async HCP engagement with proprietary intelligence built on 8.5 billion real-world data points — the same infrastructure behind successful launches at top-20 pharma companies.
One platform. Every format. Configure your programme around the science, not the software. Our rare disease advisory board achieved 92% HCP engagement across six weeks — because the format served the programme, not the other way around.
Bespoke compliance, branding and hands-on delivery — available to pharma, biotech and medcomms teams of every size, without the enterprise price tag.
Adelo is built for you if…
You’re running advisory boards or KOL programmes and need more than a platform login
You’re running advisory boards or KOL programmes and need more than a platform login
You want live, hybrid and async engagement — without managing three separate tools
You need compliance configured to your programme, not a fixed SaaS template
You’re running advisory boards or KOL programmes and need more than a platform login
You’ve been quoted enterprise pricing for capabilities you don’t fully need
You need results fast — without a 12-month commitment to find out if it works
Yes. Adelo starts from £20,000 on a flexible, pay-per-use basis with no annual contract. Within3 typically requires an enterprise annual commitment. For teams that don’t need a full enterprise licence, Adelo offers significantly better value — and a team that works with you throughout.
Footnote: Within3 pricing based on publicly available information and customer feedback.
Yes. Adelo supports studio-quality live webinars, high-production hybrid events, and in-person event integration — all within one platform. Within3 is primarily built for asynchronous engagement with limited live capability.
Footnote: Based on publicly available information and customer feedback.
Adelo builds compliance frameworks specific to your programme — including adverse event capture workflows, off-label warning management, and programme governance aligned to your regulatory obligations and internal governance. This is not an out-of-the-box SaaS feature. It is configured for each client.
Adelo’s intelligence layer is built on 8.5 billion real-world data points, covering SDOH analysis, geomapping of HCP and patient populations, medical publications tracking, and proprietary methodologies applied across programmes for top-20 pharma companies.
No annual contract. Starts from £20,000. Full delivery support and bespoke compliance included.